Anne Pernille Ofstad

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 9

Top Topics

Glycemic Control

Cardiovascular Disease

Top Venues

Diabetes, obesity & metabolism

Heart failure reviews

International journal of obesity (2005)

This page only lists publications with an associated author ORCID identifier.

Publications

Moahad S Dar, Christoph Wanner, Nikolaus Marx, Anne Pernille Ofstad, Michaela Mattheus, Stefan Kaspers, Sami A Bég
Cardiovascular outcomes trial data from EMPA-REG OUTCOME, CAROLINA and CARMELINA: Assessment of a novel staging system for type 2 diabetes. Diabetes, obesity & metabolism (2023)
Priyadarshini Balasubramanian, Walter N Kernan, Kevin Navin Sheth, Anne Pernille Ofstad, Julio Rosenstock, Christoph Wanner, Bernard Zinman, Michaela Mattheus, Nikolaus Marx, Catherine M Viscoli
Baseline Cardiovascular Risk Factor Control in Patients With Type 2 Diabetes and Coronary Disease Versus Stroke: Secondary Analysis of Cardiovascular Outcome Trials. Stroke (2023)
Anne Pernille Ofstad, Cathrine Brunborg, Odd Erik Johansen, Bjørn Mørkedal, Morten W Fagerland, Lars Erik Laugsand, Lars L Gullestad, Håvard Dalen
Development of a tool to predict the risk of incident heart failure in a general population: the HUNT for HF risk score. ESC heart failure (2023)
Sabine Kahl, Anne Pernille Ofstad, Bernard Zinman, Christoph Wanner, Elke Schueler, Naveed Sattar, Catherine M Viscoli, Michael Roden
Effects of empagliflozin on markers of liver steatosis and fibrosis and their relationship to cardiorenal outcomes. Diabetes, obesity & metabolism 24 (6) (2022)
Gerasimos S Filippatos, Javed Butler, Dimitrios Farmakis, Faiez Zannad, Anne Pernille Ofstad, Joao Pedro Ferreira, Jennifer B Green, Julio Rosenstock, Sven Schnaidt, Martina Brueckmann, Stuart J Pocock, Milton Packer, Stefan D Anker, null null
Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes. Circulation 146 (9) (2022)
Subodh Verma, Abhinav Sharma, Bernard Zinman, Anne Pernille Ofstad, David H Fitchett, Martina Brueckmann, Christoph Wanner, Isabella Zwiener, Jyothis T George, Silvio E Inzucchi, Javed Butler, C David Mazer
Empagliflozin reduces the risk of mortality and hospitalization for heart failure across Thrombolysis In Myocardial Infarction Risk Score for Heart Failure in Diabetes categories: Post hoc analysis of the EMPA-REG OUTCOME trial. Diabetes, obesity & metabolism 22 (7) (2020)
Subodh Verma, Qiuhe Ji, Deepak L Bhatt, C David Mazer, Mohammed Al-Omran, Silvio E Inzucchi, Christoph Wanner, Anne Pernille Ofstad, Isabella Zwiener, Jyothis T George, Bernard Zinman, David H Fitchett
Association between uric acid levels and cardio-renal outcomes and death in patients with type 2 diabetes: A subanalysis of EMPA-REG OUTCOME. Diabetes, obesity & metabolism 22 (7) (2020)
Anne Pernille Ofstad, Dan Atar, Lars Gullestad, Gisle Langslet, Odd Erik Johansen
The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions. Heart failure reviews 23 (3) (2019)
Anne Pernille Ofstad, Christine Sommer, Kåre I Birkeland, Marit Rokne Bjørgaas, Jon Michael Gran, Hanne Løvdal Gulseth, Odd Erik Johansen
Comparison of the associations between non-traditional and traditional indices of adiposity and cardiovascular mortality: an observational study of one million person-years of follow-up. International journal of obesity (2005) 43 (5) (2019)